Jane Street
EPZM

Jane Street’s Epizyme, Inc EPZM Stock Holding History

Jane Street’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,700
Closed -$106K – 11117
2021
Q2 		$106K Buy
+12,700
New +$107K ﹤0.01% 9233
2020
Q3 		– Sell
-25,100
Closed -$403K – 8233
2020
Q2 		$403K Buy
+25,100
New +$438K ﹤0.01% 5395

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street's EPZM Position: Q2 2022 in Review

Jane Street sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 123,930 shares — an estimated $142K sold.

Jane Street first reported a position in EPZM in Q4 2013 and held it in 15 quarters. The position peaked at $825K in Q2 2021. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Jane Street reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Jane Street sold 123,930 Epizyme, Inc shares in Q2 2022, an estimated $142K.
  • Jane Street first reported a position in Epizyme, Inc in Q4 2013 and held it in 15 quarters.
  • Jane Street's Epizyme, Inc position peaked at $825K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.